Skip to main content
Clinical Trials/NL-OMON47563
NL-OMON47563
Completed
N/A

Impact on Neurocognitive Performance in Children, Adolescents and Young Adults of Chronic Kidney Disease and its Therapy: A Feasibility Study. - The INPACT: a feasibility study

Amsterdam UMC locatie AMC0 sites40 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Amsterdam UMC locatie AMC
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusioncriteria for patients with CKD:
  • \* Patients with CKD 4\-5/ESRD or ESRD patients who underwent renal transplantation at least one years ago.
  • \* aged 8\-30 years.
  • \* Sufficient visual and hearing acuity
  • \* Dutch language fluency
  • \* Willingness to give informed consent;Inclusioncriteria for three patients with familial uremia:
  • \* Diagnosis of familial uremia.
  • \* age 12 to 50 years
  • \* Sufficient visual and hearing acuity
  • \* Dutch language fluency

Exclusion Criteria

  • For both patients and healthy controls:
  • \* Pre\-existing documented cognitive impairment
  • \* Active, uncontrolled psychiatric illness
  • \* Substance abuse
  • \* A history of cerebrovascular disease (either transitory ischaemic attack or cerebrovascular accident)
  • \* Brain injury
  • \* Epilepsy
  • \* Diabetes mellitus
  • \* Patients will be excluded from MRI scanning in case of MR contraindications, including implanted active devices or objects (e.g. cardiac pacemaker, implantable defibrillator, medication pump, intracranial aneurysm clips, cochlear implant and other implants), metal splinters near sensitive organs (e.g. eye, brain or lungs) or claustrophobia. They are eligible to participate in the other measurements of the study protocol.
  • \* Any condition that can be expected to interfere with complete follow\-up

Outcomes

Primary Outcomes

Not specified

Similar Trials